EVT

Evotec
EVT

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
€1.31B
EV
€1.42B
Shares Outstanding
177.60M
Beta
1.09

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
€11.41
P/E 2025E
-
P/Revenue 2025E
1.53x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Evotec SE

gainify
EVT

Evotec SE

EVT

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibro...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Wojczewski, Christian

Employees

4,766

IPO Date

1999-11-12

Headquarters

Essener Bogen 7, Hamburg, Hamburg, 22419, Germany

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.